Dr. Bisaga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
547 Saw Mill River Rd
Ardsley, NY 10502Phone+1 914-419-8921
Education & Training
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteFellowship, Addiction Psychiatry, 1997 - 1999
- Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside HospitalResidency, Psychiatry, 1993 - 1997
- Jagiellonian University Medical CollegeClass of 1989
Certifications & Licensure
- AR State Medical License 2021 - 2026
- NH State Medical License 2022 - 2026
- NE State Medical License 2022 - 2026
- ND State Medical License 2022 - 2026
- MT State Medical License 2022 - 2026
- NY State Medical License 1996 - 2026
- MD State Medical License 2021 - 2026
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
- Join now to see all
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2012-2016
- Westchester Magazine: Top Doctors Castle Connolly, 2012, 2015
Clinical Trials
- Memantine and Naltrexone Treatment for Opioid Dependence Start of enrollment: 2005 Jun 01
- The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1 Start of enrollment: 2004 Jan 01
- Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Changes in Recovery Capital Among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder in a Telehealth Setting.Christopher Rowe, Arthur Robin Williams, Adam Bisaga
Substance Use & Addiction Journal. 2025-01-01 - Characteristics of Adolescents with and without a Family History of Substance Use Disorder from a Minority Cohort.Keely Cheslack-Postava, Yael M Cycowicz, Diana V Rodriguez-Moreno, Lawrence V Amsel, George J Musa
Children. 2024-05-31 - Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.Matisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, Onumara Opara, Kaitlyn Ohrtman
JAMA Network Open. 2024-05-01
Journal Articles
- American Psychiatric Association PublishingAdam Bisaga, Frances R Levin, John J Mariani, Maria A Sullivan, Edward V Nunes, National Institutes of Health
- The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneBisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV, Drug Alcohol Depend, 1/1/2015
- Baseline Characteristics of Patients Predicting Suitability for Rapid Naltrexone InductionMogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes EV, Bisaga A, Am J Addictions, 1/1/2014
- Join now to see all
Press Mentions
- Unproven, UnsafeFebruary 21st, 2022
- People with Depression Twice as Likely to Use CannabisDecember 12th, 2019
- Patients Discuss Their Naltrexone ImplantsJune 18th, 2019
- Join now to see all
Grant Support
- Pioglitazone For The Treatment Of Opioid And Of Nicotine DependenceNational Institute On Drug Abuse2010–2011
- Dronabinol Naltrexone Treatment For Opioid DependenceNational Institute On Drug Abuse2009–2010
- Memantine Naltrexone Treatment For Opioid DependenceNational Institute On Drug Abuse2005–2009
- Developing Medication For Tobacco Addiction: NMDA AgentsNational Institute On Drug Abuse2003–2007
- Evaluation Of NMDA Antagonist For Opiate DependenceNational Institute On Drug Abuse1999–2003
Other Languages
- Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: